These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33237619)

  • 1. Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19-associated organ failure.
    Desterke C; Griscelli F; Imeri J; Marcoux P; Lemonnier T; Latsis T; Turhan AG; Bennaceur-Griscelli A
    Stem Cells Transl Med; 2021 Apr; 10(4):568-571. PubMed ID: 33237619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.
    Avanzini MA; Mura M; Percivalle E; Bastaroli F; Croce S; Valsecchi C; Lenta E; Nykjaer G; Cassaniti I; Bagnarino J; Baldanti F; Zecca M; Comoli P; Gnecchi M
    Stem Cells Transl Med; 2021 Apr; 10(4):636-642. PubMed ID: 33188579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells.
    Generali M; Kehl D; Wanner D; Okoniewski MJ; Hoerstrup SP; Cinelli P
    J Cell Mol Med; 2022 Jan; 26(1):228-234. PubMed ID: 34821008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells.
    Hernandez JJ; Beaty DE; Fruhwirth LL; Lopes Chaves AP; Riordan NH
    J Transl Med; 2021 Apr; 19(1):149. PubMed ID: 33853637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis.
    Schultz IC; Bertoni APS; Wink MR
    Stem Cell Rev Rep; 2021 Apr; 17(2):341-356. PubMed ID: 33511519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
    Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
    Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19.
    Bakry NS; Abdelgawad M; Abdel-Latif A; Lotfy A
    Hum Cell; 2022 Jan; 35(1):418-420. PubMed ID: 34591281
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesenchymal stem cell therapy for severe COVID-19.
    Shi L; Wang L; Xu R; Zhang C; Xie Y; Liu K; Li T; Hu W; Zhen C; Wang FS
    Signal Transduct Target Ther; 2021 Sep; 6(1):339. PubMed ID: 34497264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells Overexpressing ACE2 Favorably Ameliorate LPS-Induced Inflammatory Injury in Mammary Epithelial Cells.
    Yan S; Ye P; Aleem MT; Chen X; Xie N; Zhang Y
    Front Immunol; 2021; 12():796744. PubMed ID: 35095873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
    Sadeghi S; Soudi S; Shafiee A; Hashemi SM
    Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Study of Biological Characteristics and Transcriptome Profiles of Mesenchymal Stem Cells from Different Canine Tissues.
    Zhan XS; El-Ashram S; Luo DZ; Luo HN; Wang BY; Chen SF; Bai YS; Chen ZS; Liu CY; Ji HQ
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes.
    Valeri A; Chiricosta L; Gugliandolo A; Biasin M; Avanzini MA; Calcaterra V; Cappelletti G; Carelli S; Zuccotti GV; Silvestro S; Mazzon E; Pelizzo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.
    Saheb Sharif-Askari F; Goel S; Saheb Sharif-Askari N; Hafezi S; Al Heialy S; Hachim MY; Hachim IY; Mahboub B; Salameh L; Abdelrazig M; Elzain EI; Al-Muhsen S; Al-Hajjaj MS; Ratemi E; Hamid Q; Halwani R
    Front Immunol; 2021; 12():796094. PubMed ID: 35111161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
    Xu J; Lazartigues E
    Cell Mol Neurobiol; 2022 Jan; 42(1):305-309. PubMed ID: 32623546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
    Zhang Z; Guo L; Lu X; Zhang C; Huang L; Wang X; Duan F; Liang H; Chen P; Zeng L; Shao J; Li H; Li L; Liu L; Li C; Zhang J; Ma CY; Kwan KY; Liu W; Xu Y; Gu X; Jiang H; Du H; Zhang T; Wu Y; Yu G; Chen J; Luo R; Liao C; Tse HF; Chen Z; Chen HJ; Xia H; Lian Q
    Theranostics; 2021; 11(5):2170-2181. PubMed ID: 33500718
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration.
    Henriques-Pons A; Beghini DG; Silva VDS; Iwao Horita S; da Silva FAB
    Front Immunol; 2021; 12():780900. PubMed ID: 35095855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
    Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.